| Identification | Back Directory | [Name]
1-[[2-(3,6-Diazabicyclo[3.1.1]hept-3-yl)-7-(2-thiazolyl)-4-benzoxazolyl]oxy]-1,1-difluoro-2-methyl-2-propanol | [CAS]
2231329-25-0 | [Synonyms]
PDE4-IN-14
1-[[2-(3,6-Diazabicyclo[3.1.1]hept-3-yl)-7-(2-thiazolyl)-4-benzoxazolyl]oxy]-1,1-difluoro-2-methyl-2-propanol | [Molecular Formula]
C19H20F2N4O3S | [MOL File]
2231329-25-0.mol | [Molecular Weight]
422.45 |
| Chemical Properties | Back Directory | [Boiling point ]
599.6±60.0 °C(Predicted) | [density ]
1.424±0.06 g/cm3(Temp: 20 °C; Press: 760 Torr)(Predicted) | [form ]
Solid | [pka]
13.38±0.29(Predicted) | [color ]
White to off-white |
| Hazard Information | Back Directory | [Uses]
PDE4-IN-14 (Compound 1) is a PDE4 inhibitor that can be used in the study of PDE4-related diseases (such as inflammatory and immune diseases, cancer, and metabolic diseases, etc.)[1]. | [References]
[1] Ko KUMURA, et al. Crystal of benzoxazole derivative. Patent CA3104829A1. |
|
|